Abstract
Background Hoarding Disorder (HD) is under recognised and under-treated. Though HD develops by early adulthood, patients present only later in life, resulting in research based largely on samples of predominantly older females. Previously linked to Obsessive Compulsive Disorder (OCD), individuals with HD often have high inattention levels reminiscent of Attention Deficit/ Hyperactivity Disorder (ADHD). Here, we investigated HD in adults with ADHD.
Methods Patients in an ADHD clinic (n=88) reported on ADHD-, and OCD-related symptoms. Patients were compared to age, gender and education matched controls (n=90). Findings were compared to those in an independent online UK sample (n=220).
Results Clinically significant hoarding symptoms were found in ∼20% versus 2% of ADHD and control groups, respectively, with hoarders being on average in their thirties and balanced gender-wise. Greater hoarding severity was noted even in non-hoarding ADHD patients compared with controls (d=0.89). Inattention was the only significant statistical predictor of hoarding severity in ADHD patients. Similarly, inattention, alongside depression and anxiety were the greatest predictors of hoarding in the independent sample where 3.2% were identified as hoarders.
Conclusion Adult ADHD patients had a high frequency of hoarding symptoms, which were specifically linked to inattention. HD should be routinely assessed in ADHD patients, as they do not typically disclose associated difficulties, despite these potentially leading to impaired everyday functioning. Research in HD should investigate ADHD patients, who are younger and with a greater prevalence of males than typical HD samples.
Competing Interest Statement
SRC consults for Ieso and Promentis; and receives stipends from Elsevier for journal editorial work. All remaining authors have declared no competing interests.
Funding Statement
The study was funded by the British Academy/Leverhulme (SG152110; PI:SMZ). SRC was funded by a Wellcome Trust Clinical Fellowship (reference 110049/Z/15/A).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NHS Research Ethics Committee (16/WM/0368)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: The study was funded by the British Academy/Leverhulme (SG152110; PI:SMZ). SRC was funded by a Wellcome Trust Clinical Fellowship (reference 110049/Z/15/A).
Data Availability
Data are available from first author on request.
